ID MRDA_ECOLI Reviewed; 633 AA. AC P0AD65; P08150; DT 01-AUG-1988, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1988, sequence version 1. DT 02-SEP-2026, entry version 145. DE RecName: Full=Peptidoglycan D,D-transpeptidase MrdA {ECO:0000255|HAMAP-Rule:MF_02081, ECO:0000305}; DE EC=3.4.16.4 {ECO:0000255|HAMAP-Rule:MF_02081, ECO:0000269|PubMed:3009484, ECO:0000269|PubMed:30995398}; DE AltName: Full=Class B penicillin-binding protein 2 {ECO:0000303|PubMed:37620344}; DE AltName: Full=Penicillin-binding protein 2 {ECO:0000255|HAMAP-Rule:MF_02081, ECO:0000303|PubMed:1103132, ECO:0000303|PubMed:3009484, ECO:0000303|PubMed:30995398, ECO:0000303|PubMed:37620344}; DE Short=PBP-2 {ECO:0000255|HAMAP-Rule:MF_02081, ECO:0000303|PubMed:3009484}; DE Short=PBP2 {ECO:0000303|PubMed:30995398, ECO:0000303|PubMed:37620344}; DE AltName: Full=Transpeptidase PBP2 {ECO:0000303|PubMed:37620344}; DE Short=TP PBP2 {ECO:0000303|PubMed:37620344}; GN Name=mrdA {ECO:0000255|HAMAP-Rule:MF_02081, GN ECO:0000303|PubMed:3009484}; GN Synonyms=pbpA {ECO:0000303|PubMed:3533535, GN ECO:0000303|PubMed:3894330}; OrderedLocusNames=b0635, JW0630; OS Escherichia coli (strain K12). OC Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; OC Enterobacterales; Enterobacteriaceae; Escherichia. OX NCBI_TaxID=83333; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 1-18. RC STRAIN=K12; RX PubMed=3533535; DOI=10.1111/j.1432-1033.1986.tb09961.x; RA Asoh S., Matsuzawa H., Ishino F., Strominger J.L., Matsuhashi M., Ohta T.; RT "Nucleotide sequence of the pbpA gene and characteristics of the deduced RT amino acid sequence of penicillin-binding protein 2 of Escherichia coli RT K12."; RL Eur. J. Biochem. 160:231-238(1986). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RX PubMed=8905232; DOI=10.1093/dnares/3.3.137; RA Oshima T., Aiba H., Baba T., Fujita K., Hayashi K., Honjo A., Ikemoto K., RA Inada T., Itoh T., Kajihara M., Kanai K., Kashimoto K., Kimura S., RA Kitagawa M., Makino K., Masuda S., Miki T., Mizobuchi K., Mori H., RA Motomura K., Nakamura Y., Nashimoto H., Nishio Y., Saito N., Sampei G., RA Seki Y., Tagami H., Takemoto K., Wada C., Yamamoto Y., Yano M., RA Horiuchi T.; RT "A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to RT the 12.7-28.0 min region on the linkage map."; RL DNA Res. 3:137-155(1996). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RA Chung E., Allen E., Araujo R., Aparicio A.M., Davis K., Duncan M., RA Federspiel N., Hyman R., Kalman S., Komp C., Kurdi O., Lew H., Lin D., RA Namath A., Oefner P., Roberts D., Schramm S., Davis R.W.; RT "Sequence of minutes 4-25 of Escherichia coli."; RL Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RX PubMed=9278503; DOI=10.1126/science.277.5331.1453; RA Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V., RA Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F., RA Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B., RA Shao Y.; RT "The complete genome sequence of Escherichia coli K-12."; RL Science 277:1453-1462(1997). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RX PubMed=16738553; DOI=10.1038/msb4100049; RA Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S., RA Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.; RT "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 RT and W3110."; RL Mol. Syst. Biol. 2:E1-E5(2006). RN [6] RP PROTEIN SEQUENCE OF 321-334 AND 633, ACTIVE SITE, PENICILLIN-BINDING, AND RP MUTAGENESIS OF SER-330. RX PubMed=3148617; DOI=10.1093/oxfordjournals.jbchem.a122556; RA Takasuga A., Adachi H., Ishino F., Matsuhashi M., Ohta T., Matsuzawa H.; RT "Identification of the penicillin-binding active site of penicillin-binding RT protein 2 of Escherichia coli."; RL J. Biochem. 104:822-826(1988). RN [7] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 606-633. RC STRAIN=K12; RX PubMed=2644207; DOI=10.1128/jb.171.1.558-560.1989; RA Matsuzawa H., Asoh S., Kunai K., Muraiso K., Takasuga A., Ohta T.; RT "Nucleotide sequence of the rodA gene, responsible for the rod shape of RT Escherichia coli: rodA and the pbpA gene, encoding penicillin-binding RT protein 2, constitute the rodA operon."; RL J. Bacteriol. 171:558-560(1989). RN [8] RP FUNCTION, SUBCELLULAR LOCATION, AND ACTIVITY REGULATION. RC STRAIN=K12; RX PubMed=1103132; DOI=10.1073/pnas.72.8.2999; RA Spratt B.G.; RT "Distinct penicillin binding proteins involved in the division, elongation, RT and shape of Escherichia coli K12."; RL Proc. Natl. Acad. Sci. U.S.A. 72:2999-3003(1975). RN [9] RP DISRUPTION PHENOTYPE. RX PubMed=3894330; DOI=10.1128/jb.163.2.615-622.1985; RA Begg K.J., Donachie W.D.; RT "Cell shape and division in Escherichia coli: experiments with shape and RT division mutants."; RL J. Bacteriol. 163:615-622(1985). RN [10] RP FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, PATHWAY, AND SUBCELLULAR RP LOCATION. RX PubMed=3009484; DOI=10.1016/s0021-9258(19)62717-1; RA Ishino F., Park W., Tomioka S., Tamaki S., Takase I., Kunugita K., RA Matsuzawa H., Asoh S., Ohta T., Spratt B.G.; RT "Peptidoglycan synthetic activities in membranes of Escherichia coli caused RT by overproduction of penicillin-binding protein 2 and rodA protein."; RL J. Biol. Chem. 261:7024-7031(1986). RN [11] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=12519203; DOI=10.1046/j.1365-2958.2003.03316.x; RA Den Blaauwen T., Aarsman M.E., Vischer N.O., Nanninga N.; RT "Penicillin-binding protein PBP2 of Escherichia coli localizes RT preferentially in the lateral wall and at mid-cell in comparison with the RT old cell pole."; RL Mol. Microbiol. 47:539-547(2003). RN [12] {ECO:0007744|PDB:6G9F, ECO:0007744|PDB:6G9P, ECO:0007744|PDB:6G9S} RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 52-633 AND IN COMPLEXES WITH RP DIAZABICYCLOOCTANE INHIBITORS AVIBACTAM AND CPD4, CATALYTIC ACTIVITY, RP ACTIVITY REGULATION, PATHWAY, AND ACTIVE SITE. RC STRAIN=K12 {ECO:0000303|PubMed:30995398}; RX PubMed=30995398; DOI=10.1021/acs.jmedchem.9b00338; RA Levy N., Bruneau J.M., Le Rouzic E., Bonnard D., Le Strat F., Caravano A., RA Chevreuil F., Barbion J., Chasset S., Ledoussal B., Moreau F., Ruff M.; RT "Structural Basis for E. coli Penicillin Binding Protein (PBP) 2 RT Inhibition, a Platform for Drug Design."; RL J. Med. Chem. 62:4742-4754(2019). RN [13] {ECO:0007744|PDB:8TJ3} RP STRUCTURE BY ELECTRON MICROSCOPY (3.20 ANGSTROMS) OF FUSION CONSTRUCT OF RP MRDA AND MRDB/RODA, PATHWAY, SUBCELLULAR LOCATION, TOPOLOGY, ACTIVE SITE, RP AND MUTAGENESIS OF SER-330. RX PubMed=37620344; DOI=10.1038/s41467-023-40483-8; RA Nygaard R., Graham C.L.B., Belcher Dufrisne M., Colburn J.D., Pepe J., RA Hydorn M.A., Corradi S., Brown C.M., Ashraf K.U., Vickery O.N., RA Briggs N.S., Deering J.J., Kloss B., Botta B., Clarke O.B., Columbus L., RA Dworkin J., Stansfeld P.J., Roper D.I., Mancia F.; RT "Structural basis of peptidoglycan synthesis by E. coli RodA-PBP2 RT complex."; RL Nat. Commun. 14:5151-5151(2023). CC -!- FUNCTION: Catalyzes cross-linking of the peptidoglycan cell wall CC (PubMed:3009484). Responsible for the determination of the rod shape of CC the cell (PubMed:1103132). Is probably required for lateral CC peptidoglycan synthesis and maintenance of the correct diameter during CC lateral and centripetal growth (PubMed:12519203). CC {ECO:0000269|PubMed:1103132, ECO:0000269|PubMed:12519203, CC ECO:0000269|PubMed:3009484}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Preferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala. Also CC transpeptidation of peptidyl-alanyl moieties that are N-acyl CC substituents of D-alanine.; EC=3.4.16.4; Evidence={ECO:0000255|HAMAP- CC Rule:MF_02081, ECO:0000269|PubMed:3009484, CC ECO:0000269|PubMed:30995398}; CC -!- ACTIVITY REGULATION: Inhibited by mecillinam and benzylpenicillin CC (PubMed:1103132, PubMed:3009484). Inhibited by diazabicyclooctane CC (DBO)-based avibactam and CPD4, with IC(50) values of 0.59 uM and 0.01 CC uM, respectively (PubMed:30995398). {ECO:0000269|PubMed:1103132, CC ECO:0000269|PubMed:3009484, ECO:0000269|PubMed:30995398}. CC -!- PATHWAY: Cell wall biogenesis; peptidoglycan biosynthesis. CC {ECO:0000255|HAMAP-Rule:MF_02081, ECO:0000269|PubMed:3009484, CC ECO:0000269|PubMed:37620344, ECO:0000305|PubMed:30995398}. CC -!- INTERACTION: CC P0AD65; P02918: mrcA; NbExp=5; IntAct=EBI-1124032, EBI-1126191; CC -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP- CC Rule:MF_02081, ECO:0000269|PubMed:1103132, ECO:0000269|PubMed:3009484, CC ECO:0000305|PubMed:37620344}; Single-pass membrane protein CC {ECO:0000255|HAMAP-Rule:MF_02081, ECO:0000305|PubMed:37620344}. CC Note=Localizes preferentially in the lateral wall and at mid-cell in CC comparison with the old cell pole. Localization at mid-cell is CC dependent on active FtsI. {ECO:0000269|PubMed:12519203}. CC -!- DISRUPTION PHENOTYPE: Temperature-sensitive mutants grow as normal rods CC at 30 degrees Celsius but grow and divide as cocci during prolonged CC culturing at 42 degrees Celsius. {ECO:0000269|PubMed:3894330}. CC -!- SIMILARITY: Belongs to the transpeptidase family. MrdA subfamily. CC {ECO:0000255|HAMAP-Rule:MF_02081, ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X04516; CAA28201.1; -; Genomic_DNA. DR EMBL; U82598; AAB40835.1; -; Genomic_DNA. DR EMBL; U00096; AAC73736.1; -; Genomic_DNA. DR EMBL; AP009048; BAA35282.1; -; Genomic_DNA. DR EMBL; M22857; AAA24570.1; -; Genomic_DNA. DR PIR; C24995; ZPECP2. DR RefSeq; NP_415168.1; NC_000913.3. DR RefSeq; WP_000776191.1; NZ_CP009789.1. DR PDB; 6G9F; X-ray; 2.35 A; A=57-615. DR PDB; 6G9P; X-ray; 2.10 A; A=52-633. DR PDB; 6G9S; X-ray; 2.00 A; A=52-633. DR PDB; 8TJ3; EM; 3.20 A; C=1-633. DR AlphaFoldDB; P0AD65; -. DR MDRepo; P0AD65; -. DR SMR; P0AD65; -. DR BioGRID; 4259912; 574. DR ComplexPortal; CPX-5718; Elongasome complex. DR DIP; DIP-48190N; -. DR FunCoup; P0AD65; 507. DR IntAct; P0AD65; 6. DR STRING; 511145.b0635; -. DR ChEMBL; CHEMBL1840; -. DR ChEMBL; CHEMBL2354313; -. DR DrugBank; DB01163; Amdinocillin. DR DrugBank; DB01602; Bacampicillin. DR DrugBank; DB13028; Biapenem. DR DrugBank; DB00578; Carbenicillin. DR DrugBank; DB09319; Carindacillin. DR DrugBank; DB01327; Cefazolin. DR DrugBank; DB01413; Cefepime. DR DrugBank; DB00671; Cefixime. DR DrugBank; DB13470; Cefodizime. DR DrugBank; DB01328; Cefonicid. DR DrugBank; DB01329; Cefoperazone. DR DrugBank; DB13682; Cefpirome. DR DrugBank; DB06590; Ceftaroline fosamil. DR DrugBank; DB00438; Ceftazidime. DR DrugBank; DB01415; Ceftibuten. DR DrugBank; DB09050; Ceftolozane. DR DrugBank; DB01000; Cyclacillin. DR DrugBank; DB06211; Doripenem. DR DrugBank; DB00303; Ertapenem. DR DrugBank; DB01598; Imipenem. DR DrugBank; DB00948; Mezlocillin. DR DrugBank; DB09320; Procaine benzylpenicillin. DR DrugBank; DB16335; Sulopenem etzadroxil. DR DrugCentral; P0AD65; -. DR MEROPS; X52.001; -. DR TCDB; 8.A.254.1.1; the mrda/mrdb complex for synthesis and positioning of peptidoglycan (mrdab) family. DR jPOST; P0AD65; -. DR PaxDb; 511145-b0635; -. DR EnsemblBacteria; AAC73736; AAC73736; b0635. DR GeneID; 75170638; -. DR GeneID; 75205004; -. DR GeneID; 945240; -. DR KEGG; ecj:JW0630; -. DR KEGG; eco:b0635; -. DR KEGG; ecoc:C3026_03175; -. DR PATRIC; fig|1411691.4.peg.1633; -. DR EchoBASE; EB0601; -. DR eggNOG; COG0768; Bacteria. DR HOGENOM; CLU_009289_1_2_6; -. DR InParanoid; P0AD65; -. DR OMA; WRFGGWP; -. DR OrthoDB; 9766847at2; -. DR PhylomeDB; P0AD65; -. DR BioCyc; EcoCyc:EG10606-MONOMER; -. DR BioCyc; MetaCyc:EG10606-MONOMER; -. DR UniPathway; UPA00219; -. DR PRO; PR:P0AD65; -. DR Proteomes; UP000000625; Chromosome. DR GO; GO:0030288; C:outer membrane-bounded periplasmic space; ISM:EcoCyc. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0008658; F:penicillin binding; IDA:EcoCyc. DR GO; GO:0071972; F:peptidoglycan L,D-transpeptidase activity; IDA:EcoliWiki. DR GO; GO:0009002; F:serine-type D-Ala-D-Ala carboxypeptidase activity; IDA:UniProtKB. DR GO; GO:0071555; P:cell wall organization; IMP:EcoCyc. DR GO; GO:0009252; P:peptidoglycan biosynthetic process; IDA:UniProtKB. DR GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB. DR GO; GO:0046677; P:response to antibiotic; IMP:EcoliWiki. DR FunFam; 3.30.1390.30:FF:000001; Peptidoglycan D,D-transpeptidase MrdA; 1. DR FunFam; 3.40.710.10:FF:000004; Peptidoglycan D,D-transpeptidase MrdA; 1. DR FunFam; 3.90.1310.10:FF:000001; Peptidoglycan D,D-transpeptidase MrdA; 1. DR Gene3D; 3.40.710.10; DD-peptidase/beta-lactamase superfamily; 1. DR Gene3D; 3.90.1310.10; Penicillin-binding protein 2a (Domain 2); 1. DR Gene3D; 3.30.1390.30; Penicillin-binding protein 2a, domain 3; 1. DR HAMAP; MF_02081; MrdA_transpept; 1. DR InterPro; IPR050515; Beta-lactam/transpept. DR InterPro; IPR012338; Beta-lactam/transpept-like. DR InterPro; IPR005311; PBP_dimer. DR InterPro; IPR036138; PBP_dimer_sf. DR InterPro; IPR001460; PCN-bd_Tpept. DR InterPro; IPR017790; Penicillin-binding_protein_2. DR NCBIfam; TIGR03423; pbp2_mrdA; 1. DR NCBIfam; NF008061; PRK10795.1; 1. DR PANTHER; PTHR30627; PEPTIDOGLYCAN D,D-TRANSPEPTIDASE; 1. DR PANTHER; PTHR30627:SF2; PEPTIDOGLYCAN D,D-TRANSPEPTIDASE MRDA; 1. DR Pfam; PF03717; PBP_dimer; 1. DR Pfam; PF00905; Transpeptidase; 1. DR SUPFAM; SSF56601; beta-lactamase/transpeptidase-like; 1. DR SUPFAM; SSF56519; Penicillin binding protein dimerisation domain; 1. DR PDBsum; 6G9F; -. DR PDBsum; 6G9P; -. DR PDBsum; 6G9S; -. DR PDBsum; 8TJ3; -. PE 1: Evidence at protein level; KW 3D-structure; Carboxypeptidase; Cell inner membrane; Cell membrane; KW Cell shape; Cell wall biogenesis/degradation; Direct protein sequencing; KW Hydrolase; Membrane; Peptidoglycan synthesis; Protease; Reference proteome; KW Transmembrane; Transmembrane helix. FT CHAIN 1..633 FT /note="Peptidoglycan D,D-transpeptidase MrdA" FT /id="PRO_0000195444" FT TOPO_DOM 1..21 FT /note="Cytoplasmic" FT /evidence="ECO:0000305|PubMed:37620344" FT TRANSMEM 22..42 FT /note="Helical" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02081" FT TOPO_DOM 43..633 FT /note="Periplasmic" FT /evidence="ECO:0000305|PubMed:37620344" FT ACT_SITE 330 FT /note="Acyl-ester intermediate" FT /evidence="ECO:0000255|HAMAP-Rule:MF_02081, FT ECO:0000269|PubMed:30995398, ECO:0000269|PubMed:3148617, FT ECO:0000269|PubMed:37620344" FT MUTAGEN 330 FT /note="S->A: No longer binds fluorescent penicillin mimic FT bocellin." FT /evidence="ECO:0000269|PubMed:37620344" FT MUTAGEN 330 FT /note="S->C: No longer binds penicillin." FT /evidence="ECO:0000269|PubMed:3148617" FT HELIX 12..39 FT /evidence="ECO:0007829|PDB:8TJ3" FT HELIX 40..45 FT /evidence="ECO:0007829|PDB:8TJ3" FT HELIX 47..49 FT /evidence="ECO:0007829|PDB:8TJ3" FT STRAND 59..64 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 65..70 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 78..90 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 92..94 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 98..109 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 113..124 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 128..130 FT /evidence="ECO:0007829|PDB:8TJ3" FT STRAND 132..138 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 140..149 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 150..152 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 156..165 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 169..172 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 173..176 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 179..181 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 184..192 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 196..199 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 204..206 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 209..213 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 215..219 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 223..229 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 231..233 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 235..242 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 247..249 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 250..253 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 256..266 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 271..277 FT /evidence="ECO:0007829|PDB:6G9S" FT TURN 278..281 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 282..290 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 295..298 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 303..310 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 320..323 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 329..332 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 333..342 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 352..359 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 366..368 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 376..378 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 380..385 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 390..410 FT /evidence="ECO:0007829|PDB:6G9S" FT TURN 411..414 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 432..439 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 442..444 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 445..451 FT /evidence="ECO:0007829|PDB:6G9S" FT TURN 452..454 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 462..473 FT /evidence="ECO:0007829|PDB:6G9S" FT TURN 474..476 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 484..487 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 489..491 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 498..500 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 507..510 FT /evidence="ECO:0007829|PDB:6G9F" FT HELIX 511..524 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 531..534 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 542..548 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 571..578 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 580..582 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 585..591 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 592..594 FT /evidence="ECO:0007829|PDB:6G9S" FT STRAND 596..598 FT /evidence="ECO:0007829|PDB:6G9S" FT HELIX 600..612 FT /evidence="ECO:0007829|PDB:6G9S" SQ SEQUENCE 633 AA; 70857 MW; FE2305C002743AF6 CRC64; MKLQNSFRDY TAESALFVRR ALVAFLGILL LTGVLIANLY NLQIVRFTDY QTRSNENRIK LVPIAPSRGI IYDRNGIPLA LNRTIYQIEM MPEKVDNVQQ TLDALRSVVD LTDDDIAAFR KERARSHRFT SIPVKTNLTE VQVARFAVNQ YRFPGVEVKG YKRRYYPYGS ALTHVIGYVS KINDKDVERL NNDGKLANYA ATHDIGKLGI ERYYEDVLHG QTGYEEVEVN NRGRVIRQLK EVPPQAGHDI YLTLDLKLQQ YIETLLAGSR AAVVVTDPRT GGVLALVSTP SYDPNLFVDG ISSKDYSALL NDPNTPLVNR ATQGVYPPAS TVKPYVAVSA LSAGVITRNT TLFDPGWWQL PGSEKRYRDW KKWGHGRLNV TRSLEESADT FFYQVAYDMG IDRLSEWMGK FGYGHYTGID LAEERSGNMP TREWKQKRFK KPWYQGDTIP VGIGQGYWTA TPIQMSKALM ILINDGIVKV PHLLMSTAED GKQVPWVQPH EPPVGDIHSG YWELAKDGMY GVANRPNGTA HKYFASAPYK IAAKSGTAQV FGLKANETYN AHKIAERLRD HKLMTAFAPY NNPQVAVAMI LENGGAGPAV GTLMRQILDH IMLGDNNTDL PAENPAVAAA EDH //